TY - GEN AU - Clemons,Mark AU - Dranitsaris,George AU - Ooi,Wei AU - Cole,David E C TI - A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy SN - 0167-6806 PY - 2008///0520 KW - Administration, Oral KW - Adult KW - Aged KW - Aged, 80 and over KW - Bone Density Conservation Agents KW - administration & dosage KW - Bone Diseases KW - drug therapy KW - Bone Neoplasms KW - Bone and Bones KW - drug effects KW - Breast Neoplasms KW - complications KW - Diphosphonates KW - Female KW - Humans KW - Ibandronic Acid KW - Infusions, Intravenous KW - Middle Aged KW - Pain KW - Palliative Care KW - Pamidronate N1 - Publication Type: Clinical Trial, Phase II; Journal Article UR - https://doi.org/10.1007/s10549-007-9583-y ER -